Lasker Foundation Honors Seven, Presents New Award For First Time

SIDEBAR: For Further Reading 1996 LASKER LAUREATES: Seated, from left, are John Robbins and Rachel Schneerson; standing from left, are Ferid Murad, David Smith, Robert Furchgott, Paul Zamecnik, and Porter Anderson. The Albert and Mary Lasker Foundation entered its second half-century earlier this month by presenting a new prize along with its coveted medical research awards. For the first time in its 51-year history, the New York-based philanthropy bestowed the Albert Lasker Award for Special

Written byKaren Young Kreeger
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

SIDEBAR: For Further Reading

The 1996 Albert Lasker Basic Medical Research Award was shared by Ferid Murad, 60, the former president and CEO of Molecular Geriatrics Corp. in Lake Bluff, Ill., and Robert F. Furchgott, 80, Distinguished Professor, Emeritus, at the State University of New York Health Science Center at Brooklyn. They were honored for their fundamental research on nitric oxide, now recognized as an important biochemical messenger.

Two teams shared the 1996 Albert Lasker Clinical Medical Research Award for their research in developing a vaccine against the bacterium Haemophilis influenzae type b (Hib). John B. Robbins, 64, chief of the laboratory of developmental and molecular immunity at the National Institute of Child Health and Human Development (NICHD) and Rachel Schneerson, 64, head of the section on bacterial disease in the NICHD laboratory of developmental and molecular immunity, were jointly honored with David H. Smith, 65, the president of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies